Prof. Edgars Suna group (LIOS) in collaboration with researchers from Johannes Gutenberg University Mainz (Germany) and Tokyo Institute of Technology (Japan) have developed simple and
A novel class of selective PKM2 inhibitors as anti-cancer agents and their molecular mechanism of action have been discovered by Pavel Arsenyan (LIOS, Pharmacomodulators Synthesis
The recently published policy paper on the Efficiency of the Widening Measures, presented by Alliance4Life provides valuable insights and recommendations based on the experiences of
On May 18, 2023, the Latvian Institute of Organic Synthesis (LIOS) and Latvian Biomedical and research study centre (BMC), together with the Ministry of Education
Elina Priede, the Project Manager at Latvian Institute of Organic Synthesis, received a Widening Bursary award (EARMA Travel Grant Award) to participate in the European
Janis Veliks et al. has developed a synthetically useful approach for the straightforward preparation of fluorocyclopropylidene group from aldehydes and ketones via Julia–Kocienski olefination using
On May 4, 2023, Prof. Aigars Jirgensons, Deputy Director of the Latvian Institute of Organic Synthesis was awarded the Order of the Three Stars and
Fluoroalkyl ethers play a significant role in various fields such as pharmaceuticals, agrochemicals, nuclear imaging, and material sciences. Due to their importance, it is crucial
On April 19th (2023), the Latvian Institute of Organic Synthesis (LIOS) had the honour of welcoming the Italian ambassador to Latvia, Alessandro Monti. As part
On March 29, 2023, the Latvian Institute of Organic Synthesis (LIOS) celebrated the opening of its new Biotechnology facility. The two-story laboratory spaces are equipped
On 21st February 2023, the Latvian Institute of Organic Synthesis (LIOS) and privately owned company TBD Pharmatech OÜ, located in Estonia, signed the Memorandum of
The Scientific Committee of the Congress has developed a two-day program that includes thematic discussions, speeches, seminars, demonstrations and other activities of different formats. The
On February 16th (2023), the Latvian Institute of Organic Synthesis (LIOS) welcomed Krišjānis Kariņš – the Prime Minister of the Republic of Latvia. The Prime
The new Fragment-Screen project is born from the INFRA-2022-TECH-01 call held earlier in 2022. The project aims to develop innovative instrumentation, workflows and experimental and
On January 31, 2023, kick-off meeting of the European Union programme “Horizon Europe” ERA Chair project “Natural Products Research at Latvian Institute of Organic Synthesis
Researchers at the Organic Synthesis Laboratory (LIOS) have developed a direct oxy-monofluoromethylation of a wide range of olefinic substrates including biologically relevant molecules. For the
To encourage women to fulfil their scientific careers and take on leadership roles, on December 6 (2022) a Female Leadership workshop was held at the
On November 30, the General meeting of scientists of the Latvian Institute of Organic Synthesis (LIOS) elected the new Scientific Board (SB). 90 or 86%
The 2nd scientific conference of the Latvian Institute of Organic Synthesis (LIOS) was held on November 29 and 30 (2022). Once a year, the LIOS
The aim of the ERA Chair project “Natural Products Research at Latvian Institute of Organic Synthesis as a Driver for Excellence in Innovation (Natalion)” is
From September 22nd to 24th, the Latvian Institute of Organic Synthesis (LIOS) hosted the 2nd Drug Discovery Conference (DDC2022) in Riga, which brought together 43
Continuing studies of cobalt-catalyzed C–H bond functionalization reactions Liene Grigorjeva, PhD et al. (Organic Synthesis Methodology group) have reported an attractive methodology for obtaining 1-aminoisoquinoline
The review article by scientists from the Laboratory of Pharmaceutical Pharmacology (Latvian Institute of Organic Synthesis) and Uppsala University (Sweden) on acylcarnitines has been published
Prof. Edgars Suna’s group (Latvian Institute of Organic Synthesis) has elaborated a new synthetic approach to obtain densely substituted enantiopure cyclic sulfinamides. The method has
Input your search keywords and press Enter.